Recently added articles from TB & Outbreaks Week:
New HIV/AIDS co-infection research from University of Cape Town described.
Nov 17, 2009 ... "Combination antiretroviral treatment (CART) reduces the risk of tuberculosis in HIV-infected people. Therefore a novel approach to gain insight into protection against tuberculosis is to analyze the Tcells that expand in people sensitized by Mycobacterium tuberculosis (MTB) during CART," ...
Studies from T.D. Gruber and colleagues provide new data on enzyme research.
Nov 17, 2009 ... According to a study from the United States, "The flavoenzyme uridine 5'-diphosphate galactopyranose mutase (UGM or Glf) catalyzes the interconversion of UDP-galactopyra nose and UDP-galactofuranose. The latter Is a key building block for cell wall construction in numerous pathogens, ...
Study results from University of Amsterdam broaden understanding of HIV/AIDS co-infection.
Nov 17, 2009 ... According to a study from Netherlands, "Cooperation between different innate signaling pathways induced by pattern-recognition receptors (PRRs) on dendritic cells (DCs) is crucial for tailoring adaptive immunity to pathogens. Here we show that carbohydrate-specific signaling through the ...
New life sciences research has been reported by scientists at National Institute for Occupational Safety and Health.
Nov 17, 2009 ... "We compared the results of the tuberculin skin test with the results of the QuantiFERON-TB Gold In-Tube (QFT-GIT) assay among 182 low-risk healthcare workers," scientists in the United States report (see also Life Sciences). "Overall agreement and specificity were high, but the ...
New cancer research reported from Oregon Health & Science University.
Nov 17, 2009 ... According to recent research published in the journal Emerging Infectious Diseases, "Receiving anti-tumor necrosis factor-alpha (anti-TNF-alpha) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous ...